Compare ARDX & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | CSIQ |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 862.3M | 906.4M |
| IPO Year | 2014 | 2006 |
| Metric | ARDX | CSIQ |
|---|---|---|
| Price | $3.24 | $11.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 12 |
| Target Price | $12.90 | ★ $17.76 |
| AVG Volume (30 Days) | ★ 4.1M | 1.6M |
| Earning Date | 10-29-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,607,000.00 | N/A |
| Revenue This Year | $19.98 | N/A |
| Revenue Next Year | $27.70 | $26.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.18 | $10.34 |
| 52 Week High | $8.40 | $34.59 |
| Indicator | ARDX | CSIQ |
|---|---|---|
| Relative Strength Index (RSI) | 29.24 | 41.28 |
| Support Level | N/A | $10.34 |
| Resistance Level | $3.63 | $16.48 |
| Average True Range (ATR) | 0.11 | 0.51 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 12.50 | 54.42 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects. The company is organized in two segments: Manufacturing segment, comprising CS PowerTech, which focuses on manufacturing and sales of solar products, battery energy storage products, and other power technology products for the U.S. market and CSI Solar, which serves all other world-wide markets; and Recurrent Energy segment, which focuses on solar power and battery storage project development, asset sales, power services, and electricity revenue from its operating portfolio. It derives maximum revenue from Manufacturing segment.